EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

High expression of ARPC1B promotes the proliferation and apoptosis of clear cell renal cell carcinoma cells, leading to a poor prognosis

Hongbo Wang, Zhendong Liu, Yuelin Du, Xingbo Cheng, Shanjun Gao, Wenjia Liang, Qingyun Zhu, Zhengfa Jiang, Yanzheng Gao, Panfeng Shang

Molecular and Cellular Probes · 2025

DOI: 10.1016/j.mcp.2025.102011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular and Cellular Probes, 2025. Verfasst von Hongbo Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, China; Department of Microbiome Laboratory, Henan Provincial Peop…. Hauptthemen laut MEDLINE: Cell Proliferation, Apoptosis, Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Henan Provincial People's Hospital, Lanzhou University Second Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: ARPC1B has been identified as a key regulator of malignant biological behavior in various tumors. However, its specific role in clear cell renal cell carcinoma (ccRCC) remains poorly understood. This study aims to evaluate the influence of ARPC1B on the prognosis and disease progression in ccRCC patients. METHODS: Multi-omics data and clinical information from public databases were analyzed to determine the associations between ARPC1B and prognosis, clinical features, immune microenvironment, and drug sensitivity in ccRCC. Co-expression and gene set enrichment analyses were conducted to elucidate the potential role of ARPC1B in ccRCC pathogenesis. Functional assays, including RT-qPCR, CCK8 assays, colony formation assays, immunofluorescence, immunohistochemistry, and xenograft tumor formation in nude mice, were performed to assess ARPC1B's impact on cell proliferation and apoptosis. Flow cytometry and Western blotting were further employed to investigate the underlying molecular mechanisms of ARPC1B in ccRCC. RESULTS: ARPC1B expression was significantly elevated in ccRCC and associated with an unfavorable prognosis. Both independent and meta-analyses confirmed that ARPC1B is an independent prognostic risk factor in ccRCC. Furthermore, ARPC1B expression significantly correlated with the immune microenvironment and drug sensitivity. In vitro, experiments demonstrated that ARPC1B knockdown suppressed ccRCC cell proliferation and induced apoptosis through the BAX-Bcl-2/c-caspase3/c-PARP axis, which was further validated by in vivo studies. CONCLUSION: ARPC1B overexpression is associated with poor prognosis, altered immune status, and drug sensitivity in ccRCC. Furthermore, ARPC1B promotes the malignant behavior of ccRCC cells and holds potential as a prognostic biomarker and therapeutic target for ccRCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cell ProliferationApoptosisCarcinoma, Renal CellKidney NeoplasmsActin-Related Protein 2-3 ComplexXenograft Model Antitumor AssaysMice, NudePrognosisTumor MicroenvironmentDrug Resistance, NeoplasmGene Expression Regulation, NeoplasticGene Knockdown TechniquesBiomarkers, TumorGene Expression ProfilingFollow-Up StudiesKidneyCell LineHumansMaleAnimalsMiceMice, Inbred BALB CFemaleMiddle AgedAged

Stichwörter der Autor:innen

Actin-related protein 2/3 complexCell proliferationImmune microenvironmentPrognostic biomarkersRenal cell carcinoma

Substanzen

ARPC1B protein, humanActin-Related Protein 2-3 ComplexBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, China; Department of Microbiome Laboratory, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou Un…
  • Department of Surgery of Spine and Spinal Cord, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou, 450003, China.
  • Department of Urology Surgery, Lanzhou University Second Hospital, Lanzhou, 730030, China.
  • Department of Microbiome Laboratory, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, 450003, China.
  • Henan University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, 450003, China.
  • The First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450003, China.

Förderung

  • Henan Provincial People's Hospital
  • Lanzhou University Second Hospital

Zitieren

APA

Wang, H., Liu, Z., Du, Y., Cheng, X., Gao, S., Liang, W., Zhu, Q., Jiang, Z., Gao, Y., & Shang, P. (2025). High expression of ARPC1B promotes the proliferation and apoptosis of clear cell renal cell carcinoma cells, leading to a poor prognosis. Molecular and Cellular Probes. https://doi.org/10.1016/j.mcp.2025.102011

Vancouver

Wang H, Liu Z, Du Y, Cheng X, Gao S, Liang W, et al. High expression of ARPC1B promotes the proliferation and apoptosis of clear cell renal cell carcinoma cells, leading to a poor prognosis. Molecular and Cellular Probes. 2025. doi:10.1016/j.mcp.2025.102011

BibTeX
@article{Wang2025,
  author = {Wang, Hongbo and Liu, Zhendong and Du, Yuelin and Cheng, Xingbo and Gao, Shanjun and Liang, Wenjia and Zhu, Qingyun and Jiang, Zhengfa and Gao, Yanzheng and Shang, Panfeng},
  title = {High expression of ARPC1B promotes the proliferation and apoptosis of clear cell renal cell carcinoma cells, leading to a poor prognosis},
  journal = {Molecular and Cellular Probes},
  year = {2025},
  doi = {10.1016/j.mcp.2025.102011}
}
Kostenlos starten →